Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial
索替加利单抗和/或纳武单抗联合化疗治疗一线转移性胰腺癌:随机 2 期 PRINCE 试验的临床和免疫学分析
期刊:Nature Medicine
影响因子:58.7
doi:10.1038/s41591-022-01829-9
Lacey J Padrón #, Deena M Maurer #, Mark H O'Hara #, Eileen M O'Reilly, Robert A Wolff, Zev A Wainberg, Andrew H Ko, George Fisher, Osama Rahma, Jaclyn P Lyman, Christopher R Cabanski, Jia Xin Yu, Shannon M Pfeiffer, Marko Spasic, Jingying Xu, Pier Federico Gherardini, Joyson Karakunnel, Rosemarie M